409 related articles for article (PubMed ID: 26553470)
21. Functional restoration of a CFTR splicing mutation through RNA delivery of CRISPR adenine base editor.
Amistadi S; Maule G; Ciciani M; Ensinck MM; De Keersmaecker L; Ramalho AS; Guidone D; Buccirossi M; Galietta LJV; Carlon MS; Cereseto A
Mol Ther; 2023 Jun; 31(6):1647-1660. PubMed ID: 36895161
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneous spectrum of mutations in CFTR gene from Indian patients with congenital absence of the vas deferens and their association with cystic fibrosis genetic modifiers.
Sharma H; Mavuduru RS; Singh SK; Prasad R
Mol Hum Reprod; 2014 Sep; 20(9):827-35. PubMed ID: 24958810
[TBL] [Abstract][Full Text] [Related]
23. Validation of CFTR intronic variants identified during cystic fibrosis population screening by a minigene splicing assay.
Giorgi G; Casarin A; Trevisson E; Donà M; Cassina M; Graziano C; Picci L; Clementi M; Salviati L
Clin Chem Lab Med; 2015 Oct; 53(11):1719-23. PubMed ID: 25781545
[TBL] [Abstract][Full Text] [Related]
24. Antisense oligonucleotide-mediated correction of CFTR splicing improves chloride secretion in cystic fibrosis patient-derived bronchial epithelial cells.
Michaels WE; Bridges RJ; Hastings ML
Nucleic Acids Res; 2020 Jul; 48(13):7454-7467. PubMed ID: 32520327
[TBL] [Abstract][Full Text] [Related]
25. Comparative ex vivo, in vitro and in silico analyses of a CFTR splicing mutation: Importance of functional studies to establish disease liability of mutations.
Ramalho AS; Clarke LA; Sousa M; Felicio V; Barreto C; Lopes C; Amaral MD
J Cyst Fibros; 2016 Jan; 15(1):21-33. PubMed ID: 25735457
[TBL] [Abstract][Full Text] [Related]
26. mRNA-based detection of rare CFTR mutations improves genetic diagnosis of cystic fibrosis in populations with high genetic heterogeneity.
Felício V; Ramalho AS; Igreja S; Amaral MD
Clin Genet; 2017 Mar; 91(3):476-481. PubMed ID: 27174726
[TBL] [Abstract][Full Text] [Related]
27. Altered Pre-mRNA Splicing Caused by a Novel Intronic Mutation c.1443+5G>A in the Dihydropyrimidinase (DPYS) Gene.
Nakajima Y; Meijer J; Zhang C; Wang X; Kondo T; Ito T; Dobritzsch D; Van Kuilenburg AB
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26771602
[TBL] [Abstract][Full Text] [Related]
28. Spliceosome-mediated RNA trans-splicing with recombinant adeno-associated virus partially restores cystic fibrosis transmembrane conductance regulator function to polarized human cystic fibrosis airway epithelial cells.
Liu X; Luo M; Zhang LN; Yan Z; Zak R; Ding W; Mansfield SG; Mitchell LG; Engelhardt JF
Hum Gene Ther; 2005 Sep; 16(9):1116-23. PubMed ID: 16149910
[TBL] [Abstract][Full Text] [Related]
29. Characterization of a disease-associated mutation affecting a putative splicing regulatory element in intron 6b of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Faà V; Incani F; Meloni A; Corda D; Masala M; Baffico AM; Seia M; Cao A; Rosatelli MC
J Biol Chem; 2009 Oct; 284(44):30024-31. PubMed ID: 19759008
[TBL] [Abstract][Full Text] [Related]
30. Cystic fibrosis patients with the 3272-26A-->G mutation have mild disease, leaky alternative mRNA splicing, and CFTR protein at the cell membrane.
Beck S; Penque D; Garcia S; Gomes A; Farinha C; Mata L; Gulbenkian S; Gil-Ferreira K; Duarte A; Pacheco P; Barreto C; Lopes B; Cavaco J; Lavinha J; Amaral MD
Hum Mutat; 1999; 14(2):133-44. PubMed ID: 10425036
[TBL] [Abstract][Full Text] [Related]
31. Characterization of an intron 12 splice donor mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Strong TV; Smit LS; Nasr S; Wood DL; Cole JL; Iannuzzi MC; Stern RC; Collins FS
Hum Mutat; 1992; 1(5):380-7. PubMed ID: 1284540
[TBL] [Abstract][Full Text] [Related]
32. Detection of a large heterozygous deletion and a splicing defect in the CFTR transcripts from nasal swab of a Japanese case of cystic fibrosis.
Nakakuki M; Fujiki K; Yamamoto A; Ko SB; Yi L; Ishiguro M; Yamaguchi M; Kondo S; Maruyama S; Yanagimoto K; Naruse S; Ishiguro H
J Hum Genet; 2012 Jul; 57(7):427-33. PubMed ID: 22572733
[TBL] [Abstract][Full Text] [Related]
33. Antisense Oligonucleotide Therapeutics for Cystic Fibrosis: Recent Developments and Perspectives.
Kim YJ; Krainer AR
Mol Cells; 2023 Jan; 46(1):10-20. PubMed ID: 36697233
[TBL] [Abstract][Full Text] [Related]
34. Fine characterization of the recurrent c.1584+18672A>G deep-intronic mutation in the cystic fibrosis transmembrane conductance regulator gene.
Costantino L; Rusconi D; Soldà G; Seia M; Paracchini V; Porcaro L; Asselta R; Colombo C; Duga S
Am J Respir Cell Mol Biol; 2013 May; 48(5):619-25. PubMed ID: 23349053
[TBL] [Abstract][Full Text] [Related]
35. Whole-gene CFTR sequencing combined with digital RT-PCR improves genetic diagnosis of cystic fibrosis.
Straniero L; Soldà G; Costantino L; Seia M; Melotti P; Colombo C; Asselta R; Duga S
J Hum Genet; 2016 Dec; 61(12):977-984. PubMed ID: 27488443
[TBL] [Abstract][Full Text] [Related]
36. Short communication: novel truncating mutations in the CFTR gene causing a severe form of cystic fibrosis in Italian patients.
Lenarduzzi S; Morgutti M; Crovella S; Coiana A; Rosatelli MC
Genet Mol Res; 2014 Nov; 13(4):9636-41. PubMed ID: 25501174
[TBL] [Abstract][Full Text] [Related]
37. Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations.
Nissim-Rafinia M; Chiba-Falek O; Sharon G; Boss A; Kerem B
Hum Mol Genet; 2000 Jul; 9(12):1771-8. PubMed ID: 10915765
[TBL] [Abstract][Full Text] [Related]
38. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
[TBL] [Abstract][Full Text] [Related]
39. The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C-->T mutation.
Chiba-Falek O; Kerem E; Shoshani T; Aviram M; Augarten A; Bentur L; Tal A; Tullis E; Rahat A; Kerem B
Genomics; 1998 Nov; 53(3):276-83. PubMed ID: 9799593
[TBL] [Abstract][Full Text] [Related]
40. Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element.
Pagani F; Buratti E; Stuani C; Romano M; Zuccato E; Niksic M; Giglio L; Faraguna D; Baralle FE
J Biol Chem; 2000 Jul; 275(28):21041-7. PubMed ID: 10766763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]